L01FG01 Bevacizumab biosimilar 400 mg/16 ml

Tender information

TED EU

Skopje, North Macedonia

Type: 20
Ref. number: 414635-2026
CPV: 33600000

Procurement of medicines for 2026 Biological therapy

Show all tender information

Documents

Show all important dates